Optimal duration of therapy in the first line treatment of metastatic colorectal cancer: Single center experience

Background/Aim. Standard treatment options for the first-line treatment of metastatic colorectal carcinoma (mCRC) are 5-fluorouracil, folinic acid, oxaliplatin (FOL-FOX4)/capecitabine (CapOx), plus bevacizumab (bev) and 5-fluorouracil, folinic acid and irinotecan (FOLFIRI) plus bev. The aim of this...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jungić Saša, Tubić Biljana, Berendika Jelena, Gojković Zdenka, Rakita Ivanka, Vještica Milka, Đokanović Dejan, Gajanin Radoslav
Format:	Article
Language:	English
Published:	Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2022-01-01
Series:	Vojnosanitetski Pregled
Subjects:	clinical protocols colorectal neoplasms drug-related side effects and adverse reactions duration of therapy folfox protocol ifl protocol neoplasm metastasis survival
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2022/0042-84502100053J.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Optimal duration of therapy in the first line treatment of metastatic colorectal cancer: Single center experience

Similar Items